Persistence of Suspected Probiotic Organisms in Preterm Infant Gut Microbiota Weeks After Probiotic Supplementation in the NICU

Frontiers in Microbiology
Q1
Sep 2020
Citations:25
Influential Citations:2
Observational Studies (Human)
80
S2 IconPDF Icon

Enhanced Details

Methods
Design: prospective, longitudinal, observational; Population: preterm infants enrolled within 72 h of birth at McMaster Children's Hospital or St. Joseph’s Healthcare Hamilton; early preterm defined as gestational age <32 weeks (GA 22 w 6 d to 30 w 3 d); 22 infants analyzed (8 probiotic-exposed, 14 unexposed); comparator full-term cohort included (n=51); stool samples collected in-hospital and at term, 6 weeks, 12 weeks, and 5 months corrected age; 16S rRNA gene sequencing of the V3 region used to profile gut microbiota.
Intervention
FloraBABY probiotic, 0.5 g sachet containing 2 x 10^9 CFU per dose, mixed with 1 mL expressed breastmilk or sterile water; given daily; started in-hospital around 30.3-36.1 weeks postmenstrual age and continued until discharge or transfer; in-hospital duration 3.29-13.57 weeks.
Results
Probiotic exposure increased the relative abundance of four Bifidobacterium ASVs during supplementation (ASV 202: B. longum; ASV 203: B. longum; ASV 204: B. bifidum; ASV 205: B. breve) and one Lactobacillus ASV (ASV 2940) to ~6-21% and 98% prevalence (2% average) respectively during in-hospital administration; signals persisted up to 5 months corrected age. Probiotic-exposed preterm infants’ microbiomes at term corrected age clustered more closely with 10-day-old full-term infants than did unexposed preterms, indicating earlier convergence toward a full-term-like microbiome. Lactobacillus signals were less clear post-discontinuation, and antibiotic exposure reduced Lactobacillus. Authors conclude that routine in-hospital probiotic administration can lead to colonization by probiotic organisms after discharge and alter the gut microbiome as a whole; further research is needed to distinguish probiotic from endogenous strains, assess functional health effects, and optimize dosage/duration.
Limitations
Small, single-center sample (n=22 preterm); non-randomized natural experiment; variable sampling timing; no placebo-control for maltodextrin in FloraBABY; limited resolution to distinguish probiotic strains from endogenous bacteria; potential cross-colonization; antibiotic exposure and breastfeeding as confounders.

Abstract

Probiotics are becoming a prevalent supplement to prevent necrotizing enterocolitis in infants born preterm. However, little is known about the ability of these live bacterial supplements to colonize the gut or how they affect endogenous bacterial st...